Patient-Controlled Analgesia Pump are Gaining Traction as the Prevalence of Chronic Pain Conditions Rises

The increasing prevalence of chronic pain conditions such as cancer, arthritis and fibromyalgia, as well as advancements in technology with increased safety features in PCA pumps, are driving market expansion. The increasing number of cases of fibromyalgia contributes to the expansion of the patient-controlled analgesia pump market. For instance, according to Centres for Disease Control and Prevention (CDC) data updated in May 2022, around 4 million US citizens, or 2% of all adults, suffer with fibromyalgia. Although there is no known cause of fibromyalgia, it is curable and controllable with a variety of pain management methods, including a patient-controlled analgesia pump. Additionally, in the United States, 22.9% of individuals reported having chronic pain in 2023. As a consequence of the increased incidence of chronic pain diseases such as fibromyalgia, the usage of patient-controlled analgesia pumps is increasing and driving market growth over the forecast period.
Patient-Controlled Analgesia Pump Market

Oncology Segment is Driving the Growth of the Patient-Controlled Analgesia Pump Market

Oncology is anticipated to hold a sizable market share over the forecast period. The demand for PCA pumps is anticipated to rise along with the rising incidence of cancer since cancer pain is usually characterised as a pressing, throbbing, burning, or tingling feeling that may be controlled with PCA pumps. Cancer affects around one in every five Canadians and kills approximately one in every four. According to the ACS, there will likely be 1.95 million new cases of cancer and 609,820 cancer-related deaths in the United States in 2023.  As a result of the increased number of new cancer cases in the region, there will be a higher demand for pain treatment, which may be achieved via patient-controlled analgesia pumps. Physicians provide very strong opioid medicines such as morphine, hydro morphine and fentanyl via patient-controlled analgesia (PCA) infusion to relieve intolerable pain. The segment's expansion is anticipated to be supported by the increasing use of PCA pumps in such conditions to enhance quality of life.

Recent Trends in Patient-Controlled Analgesia Pumps Market Industry:

  • Integration of smart technologies and wireless connectivity for better pain management.
  • Growing preference for PCA pumps in hospitals and outpatient settings.
  • Development of user-friendly and portable PCA pumps to enhance patient comfort.
  • Surge in FDA approvals and CE markings for innovative PCA devices.
Explore Our Breakthrough Market Segmentation and Personalize it to Meet Your Business Needs…!

Lack of Skilled Specialists and the Absence of a Strong Regulatory Structure are Likely to Pose Challenges

Experts and professionals are in high demand both in developed and developing nations. Despite considerable expenditures, the global patient-controlled analgesia pumps market's progress will be hampered by a shortage of experienced specialists and professionals throughout the forecast period. A lack of skilled professionals may impede the successful utilization and supervision of cutting-edge technologies, possibly resulting in less than ideal patient results and inefficiencies in operations. Furthermore, the lack of strong regulatory structures could lead to variations in norms and procedures, making it harder to create and implement new solutions. The lack of adequate healthcare infrastructure in developing regions such as the Middle East, Africa and Latin America may hamper demand for advanced patient-controlled analgesia pumps and limit market growth for patient-controlled analgesia pumps throughout the forecast period. The lack of a suitable regulatory framework for medical operations, including the use of patient-controlled analgesia pumps, further hinders the growth of the market for such devices.

Partnerships and Innovation are Fuelling Growth in the Patient-Controlled Analgesia (PCA) pump market

Collaborations and creativity are fuelling expansion in the Patient-Controlled Analgesia (PCA) pump industry. Partnerships between tech developers and healthcare providers are making it easier to combine advanced features and improve the functionality of PCA pumps. At the same time, advancements in pump technology and software are enhancing patient results through providing more accurate pain control and easier-to-use interfaces. These elements are leading to a more energetic and competitive market, focusing on providing innovative solutions to address changing healthcare demands. For instance, in April 2022, Smith’s Medical established a partnership with Bainbridge Health. The collaboration aimed to give pharmacy and safety experts insight into developing trends in intravenous drug safety and use. Additionally, BD signed the final agreement to acquire Parata Systems for US$ 1.525 billion in January 2022.
Know Your Competitors and Strengthen Market Share Effectively

North America has a Potential Market Opportunity for the Patient-Controlled Analgesia Pumps Market

North America is anticipated to dominate the total PCA pumps market attributed to an increase in the number of accidental injuries, cases of cancer and other pain-related conditions as well as an increase in chronic pain research funding. The increasing frequency of cancer cases in North America is projected to fuel market expansion. According to the ACS, around 1.9 million new cancer cases identified and 609,360 cancer deaths in the United States in 2022. As a result, the increased frequency of cancer cases in the region is expected to enhance market growth in the region over the forecast period. Furthermore, an increase in chronic pain research funding is likely to drive market expansion in the region. In accordance with NIH 2023, research funding for chronic pain in the United States is expected to be US$ 838 million in 2023. Such efforts are anticipated to increase the portfolio of companies, which is expected to grow significantly in the North American region throughout the forecast period.
Searching for a Country or Region-Specific Report?

Unlock industry complexities with reports crafted for selected countries and regions at Reduced Cost

The report provides a detailed overview of the patient-controlled analgesia pump market insights in regions including North America, Latin America, Europe, Asia-Pacific, Oceania, and the Middle East and Africa. The country-specific assessment for patient-controlled analgesia pump market has been offered for all regional market share, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the patient-controlled analgesia pump market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the patient-controlled analgesia pump market. Some key country and region included in the patient-controlled analgesia pump market report as follows:
Regions Countries
North America United States, Canada
Latin America Brazil, Mexico, Argentina, Colombia, Chile, Rest of Latin America
Europe Germany, United Kingdom, France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Norway, Denmark, Finland, Ireland, Czech Republic, Rest of Europe
Asia Pacific China, India, Japan, South Korea, Australia & New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific
Middle East and Africa GCC Countries, South Africa, Egypt, Turkey, Morocco, Israel, Iran, Kenya, Nigeria, Rest of MEA

Patient-Controlled Analgesia Pump Market Research Report Covers In-depth Analysis on:

  • Patient-controlled analgesia pump market detailed segments and segment-wise market breakdown
  • Patient-controlled analgesia pump market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in patient-controlled analgesia pump industry)
  • Current, historical and forthcoming 10 years market valuation in terms of patient-controlled analgesia pump market size (US$ Mn), volume (Units), share (%), Y-o-Y growth rate, CAGR (%) analysis
  • Patient-controlled analgesia pump market demand analysis
  • Patient-controlled analgesia pump market pricing analysis over forecast period (by key segment and by region)
  • Patient-controlled analgesia pump market regional insights with region-wise market breakdown
  • Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
  • Latest developments and innovations in patient-controlled analgesia pump market
  • Regulatory landscape by key regions and key countries
  • Supply chain and value chain analysis in patient-controlled analgesia pump market
  • Patient-controlled analgesia pump market sales and distribution strategies
  • A comprehensive overview of parent market
  • A detailed viewpoint on patient-controlled analgesia pump market forecast by countries
  • Mergers and acquisitions in patient-controlled analgesia pump market
  • Essential information to enhance market position
  • Robust research methodology

- Frequently Asked Questions -

How is the patient-controlled analgesia pump market expected to grow over the next decade?

The market is anticipated to experience significant growth, driven by increasing surgical procedures, advancements in medical technology, and rising awareness of pain management options.

What factors are driving the growth of the patient-controlled analgesia pump market?

Key factors include the growing geriatric population, rising prevalence of chronic pain conditions and the increasing demand for effective pain management solutions.

What is the competitive landscape of the patient-controlled analgesia pump market?

The market features several key players, including medical device manufacturers and pharmaceutical companies, focusing on innovation, strategic partnerships and enhancing product offerings to gain market share.